LEICeSter Tendon Extracorporeal Shockwave Studies

Launched by UNIVERSITY HOSPITALS, LEICESTER · Sep 7, 2015

Keywords

ClinConnect Summary

The LEICeSter Tendon Extracorporeal Shockwave Studies trial is investigating whether adding Extra-corporeal Shockwave Therapy (ESWT) to a home-exercise program can help people with tendinopathy, which is a condition that causes pain and stiffness in tendons. This trial is currently looking for participants aged 18 and older who have been experiencing symptoms for at least 12 weeks related to specific tendon issues, such as plantar fasciitis or tennis elbow. Participants must also have imaging tests confirming their diagnosis and showing no serious injuries.

If you decide to join the trial, you will receive both the ESWT treatment and guidance on exercises to do at home. This study is important because it aims to discover whether combining these two approaches can lead to better results for managing tendinopathy. However, certain individuals may not qualify, like those who have had recent treatments that could interfere with the study. It's a great opportunity for those struggling with tendon issues to potentially find relief through this innovative approach.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients age \>18
• 2. Symptoms (typically pain / stiffness) of at least 12 weeks of one of the following sites / conditions:
• • 1. Plantar fasciitis
• • 2. Insertional Achilles tendinopathy
• • 3. Mid-substance Achilles tendinopathy
• • 4. Patella tendinopathy
• • 5. Trochanteric pain syndrome (gluteus medius insertional tendinopathy / trochanteric bursitis)
• • 6. Tennis elbow
• • 3. Referred for ESWT (shockwave) within the Sports Medicine Department
• • 4. Objective imaging of tendon / structure confirming diagnosis and excluding tear or other structural injury (US or MRI acceptable)
• Exclusion Criteria:
• • 1. Patients with the normal exclusions for ESWT - including pre-existing skin injury over tendon site, recent steroid injection (within 6 weeks of ESWT starting), patients on anticoagulation, patients with haemophilia or other bleeding tendency, patients with current febrile illness
• • 2. Previous ESWT treatment for the same condition